Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma. (Q45212331)

From Wikidata
Jump to navigation Jump to search
scientific article published in December 2006
edit
Language Label Description Also known as
English
Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma.
scientific article published in December 2006

    Statements

    title
    Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    17145617
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17145617%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    22 December 2019

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q45212331&oldid=2010746760"